Search Results

Filter
  • 1-10 of  556 results for ""FORMOTEROL""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

A network meta-analysis of the association between patient traits and response to regular dosing with ICS plus short-acting β 2 -agonist reliever or ICS/formoterol reliever only in mild asthma.

Subjects: Asthma*/Asthma*/Asthma*/drug therapy ; Formoterol Fumarate*/Formoterol Fumarate*/Formoterol Fumarate*/administration & dosage ; Adrenal Cortex Hormones*/Adrenal Cortex Hormones*/Adrenal Cortex Hormones*/administration & dosage

  • Source: Respiratory medicine [Respir Med] 2024 May; Vol. 226, pp. 107610. Date of Electronic Publication: 2024 Mar 30.Publisher: Elsevier Country of Publication: England NLM ID: 8908438 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Effect of a single day of increased as-needed budesonide-formoterol use on short-term risk of severe exacerbations in patients with mild asthma: a post-hoc analysis of the SYGMA 1 study.

  • Authors : O'Byrne PM; Firestone Institute for Respiratory Health, St Joseph's Healthcare and Department of Medicine, Michael G DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada. Electronic address: .; FitzGerald JM

Subjects: Asthma/Asthma/Asthma/*drug therapy ; Bronchodilator Agents/Bronchodilator Agents/Bronchodilator Agents/*therapeutic use ; Budesonide/Budesonide/Budesonide/*therapeutic use

  • Source: The Lancet. Respiratory medicine [Lancet Respir Med] 2021 Feb; Vol. 9 (2), pp. 149-158. Date of Electronic Publication: 2020 Oct 01.Publisher: Elsevier Country of Publication: England NLM ID: 101605555 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Mitochondrial biogenesis induced by the β2-adrenergic receptor agonist formoterol accelerates podocyte recovery from glomerular injury.

  • Authors : Arif E; Department of Medicine, Nephrology Division, Medical University of South Carolina, Charleston, South Carolina, USA.; Solanki AK

Subjects: Adrenergic beta-2 Receptor Agonists/Adrenergic beta-2 Receptor Agonists/Adrenergic beta-2 Receptor Agonists/*pharmacology ; Formoterol Fumarate/Formoterol Fumarate/Formoterol Fumarate/*pharmacology ; Glomerulonephritis/Glomerulonephritis/Glomerulonephritis/*drug therapy

  • Source: Kidney international [Kidney Int] 2019 Sep; Vol. 96 (3), pp. 656-673. Date of Electronic Publication: 2019 May 06.Publisher: Elsevier Country of Publication: United States NLM ID: 0323470 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Comparing the efficacy and safety of formoterol/budesonide pMDI versus its mono-components and other LABA/ICS in patients with asthma.

Subjects: Adrenal Cortex Hormones/Adrenal Cortex Hormones/Adrenal Cortex Hormones/*administration & dosage ; Adrenergic beta-2 Receptor Agonists/Adrenergic beta-2 Receptor Agonists/Adrenergic beta-2 Receptor Agonists/*administration & dosage ; Asthma/Asthma/Asthma/*drug therapy

  • Source: Respiratory medicine [Respir Med] 2020 Aug - Sep; Vol. 170, pp. 106055. Date of Electronic Publication: 2020 Jun 01.Publisher: Elsevier Country of Publication: England NLM ID: 8908438 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Efficacy and safety of glycopyrrolate/formoterol fumarate metered dose inhaler delivered using co-suspension delivery technology in Japanese patients with moderate-to-very severe chronic obstructive pulmonary disease.

  • Authors : Gon Y; Nihon University School of Medicine, Division of Respiratory Medicine, Itabashi, Tokyo, Japan. Electronic address: .; Nishi K

Subjects: Drug Delivery Systems/Drug Delivery Systems/Drug Delivery Systems/*methods ; Formoterol Fumarate/Formoterol Fumarate/Formoterol Fumarate/*administration & dosage ; Glycopyrrolate/Glycopyrrolate/Glycopyrrolate/*administration & dosage

  • Source: Respiratory investigation [Respir Investig] 2021 Jan; Vol. 59 (1), pp. 135-144. Date of Electronic Publication: 2020 Sep 08.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101581124 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells.

  • Authors : Yamaya M; Department of Advanced Preventive Medicine for Infectious Disease, Tohoku University School of Medicine, Sendai, Japan. Electronic address: .; Nishimura H

Subjects: Adrenergic beta-2 Receptor Agonists/Adrenergic beta-2 Receptor Agonists/Adrenergic beta-2 Receptor Agonists/*pharmacology ; Budesonide/Budesonide/Budesonide/*pharmacology ; Coronavirus/Coronavirus/Coronavirus/*physiology

  • Source: Respiratory investigation [Respir Investig] 2020 May; Vol. 58 (3), pp. 155-168. Date of Electronic Publication: 2020 Feb 21.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101581124 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Randomized study of the effects of Aerochamber Plus ® Flow-Vu ® on the efficacy, pharmacokinetics and safety of glycopyrronium/formoterol fumarate dihydrate metered dose inhaler in patients with chronic obstructive pulmonary disease.

  • Authors : Fakih F; Florida Premier Research Institute, LLC, Winter Park, FL, USA. Electronic address: .; Spangenthal S

Subjects: Metered Dose Inhalers*; Formoterol Fumarate/Formoterol Fumarate/Formoterol Fumarate/*administration & dosage ; Glycopyrrolate/Glycopyrrolate/Glycopyrrolate/*administration & dosage

  • Source: Respiratory medicine [Respir Med] 2018 May; Vol. 138, pp. 74-80. Date of Electronic Publication: 2018 Mar 30.Publisher: Elsevier Country of Publication: England NLM ID: 8908438 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Pulmonary deposition of fluticasone propionate/formoterol in healthy volunteers, asthmatics and COPD patients with a novel breath-triggered inhaler.

  • Authors : Kappeler D; Inamed GmbH, Robert-Koch-Allee 29, Gauting, Germany. Electronic address: .; Sommerer K

Subjects: Metered Dose Inhalers*; Asthma/Asthma/Asthma/*metabolism ; Bronchodilator Agents/Bronchodilator Agents/Bronchodilator Agents/*administration & dosage

  • Source: Respiratory medicine [Respir Med] 2018 May; Vol. 138, pp. 107-114. Date of Electronic Publication: 2018 Mar 29.Publisher: Elsevier Country of Publication: England NLM ID: 8908438 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Budesonide + formoterol delivered via Spiromax ® for the management of asthma and COPD: The potential impact on unscheduled healthcare costs of improving inhalation technique compared with Turbuhaler ® .

Subjects: Asthma/Asthma/Asthma/*drug therapy ; Budesonide/Budesonide/Budesonide/*therapeutic use ; Budesonide, Formoterol Fumarate Drug Combination/Budesonide, Formoterol Fumarate Drug Combination/Budesonide, Formoterol Fumarate Drug Combination/*therapeutic use

  • Source: Respiratory medicine [Respir Med] 2017 Aug; Vol. 129, pp. 179-188. Date of Electronic Publication: 2017 Jun 27.Publisher: Elsevier Country of Publication: England NLM ID: 8908438 Publication Model: Print-Electronic Cited Medium:

Record details

×
  • 1-10 of  556 results for ""FORMOTEROL""